Skip to main content
Livermore
Livermore
ZHEN

Bellevue Asset Management, LLC

SEC CIK
0001801619
Latest filing
Aug 4, 2026

The latest 13F from Bellevue Asset Management, LLC covers Q2 2026 (filed Aug 4, 2026): 578 long positions worth $216.7M. The top 10 holdings make up 58.4% of the portfolio, and the largest is Microsoft Corp (MSFT) at 22.4%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
222
Est. +$2.35M
Added
105
Est. +$1.40M
Reduced
52
Est. −$6.75M
Sold out
13
Est. −$437.0K

Top 5 holdings

Share of this quarter's portfolio value

  1. MSFTMicrosoft Corp
    22.4%$48.5MHistory
  2. AAPLApple Inc.
    7.2%$15.5MHistory
  3. Capital Group Growth ETF14020G101
    5.5%$11.8M
  4. First Trust Rising Dividend Achievers ETF33738R506
    5.4%$11.6M
  5. First Tr Exchange-Traded FD33739Q200
    4.1%$8.95M

Share of portfolio

Top 5 holdings and the other 573 positions, by share of portfolio value

  1. MSFT22.4%
  2. AAPL7.2%
  3. Capital Group Growth ETF5.5%
  4. First Trust Rising Dividend Achievers ETF5.4%
  5. First Tr Exchange-Traded FD4.1%
  6. Other 573 positions55.5%

Biggest buys

New and added positions, by estimated amount bought

  1. First Tr Exchange-Traded FD33739Q408
    +$1.10MAdded
  2. Trust for Professional Manag89834G570
    +$887.7KNew
  3. PMPhilip Morris International Inc.
    +$294.9KNewHistory
  4. iShares Core S&P U.S. Growth ETF464287671
    +$154.6KNew
  5. iShares Core S&P US Value ETF464287663
    +$147.2KNew

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. INTCIntel Corp
    +0.56 pp0.3% → 0.8%History
  2. Trust for Professional Manag89834G570
    +0.41 pp0.0% → 0.4%
  3. First Tr Exchange-Traded FD33739Q408
    +0.34 pp2.1% → 2.4%
  4. CSCOCisco Systems, Inc.
    +0.16 pp0.4% → 0.5%History
  5. PMPhilip Morris International Inc.
    +0.14 pp0.0% → 0.1%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. AMZNAmazon Com Inc
    −$1.25MReducedHistory
  2. NVDANVIDIA Corp
    −$1.18MReducedHistory
  3. First Tr Exchange-Traded FD33739Q200
    −$696.1KReduced
  4. J P Morgan Exchange Traded F46641Q274
    −$523.3KReduced
  5. TCW ETF Trust29287L700
    −$514.0KReduced

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. MSFTMicrosoft Corp
    −1.80 pp24.2% → 22.4%History
  2. First Tr Exchange-Traded FD33739Q200
    −0.70 pp4.8% → 4.1%
  3. NVDANVIDIA Corp
    −0.48 pp1.2% → 0.7%History
  4. COSTCostco Wholesale Corp
    −0.47 pp3.3% → 2.9%History
  5. J P Morgan Exchange Traded F46641Q274
    −0.42 pp2.2% → 1.8%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$216.7M
+$16.9M (+8.5%) vs. prior quarter
Positions
578
+209 vs. prior quarter
Top 10 concentration
58.4%
Top 10 as share of value
Turnover
1.8%
Q2 2026, one quarter
Average holding period
18.1 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $217.3M (Q3 2025)

Q1 2021: $161.3MQ2 2021: $163.9MQ3 2021: $163.4MQ4 2021: $169.7MQ1 2022: $163.1MQ2 2022: $137.0MQ3 2022: $128.6MQ4 2022: $129.3MQ1 2023: $147.4MQ2 2023: $159.4MQ3 2023: $148.8MQ4 2023: $113.2MQ1 2024: $176.2MQ2 2024: $181.1MQ3 2024: $194.7MQ4 2024: $193.7MQ1 2025: $183.3MQ2 2025: $205.5MQ3 2025: $217.3MQ4 2025: $207.0MQ1 2026: $199.8MQ2 2026: $216.7M
Q1 2021Q2 2026
13F filings of Bellevue Asset Management, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 4, 2026578$216.7MMSFTAAPLCapital Group Growth ETFvs. Q1 2026SEC
Q1 2026Apr 24, 2026369$199.8MMSFTAAPLCapital Group Growth ETFvs. Q4 2025SEC
Q4 2025Jan 23, 2026489$207.0MMSFTAAPLCapital Group Growth ETFvs. Q3 2025SEC
Q3 2025Nov 4, 2025487$217.3MMSFTAAPLCapital Group Growth ETFvs. Q2 2025SEC
Q2 2025Jul 23, 2025472$205.5MMSFTAAPLCapital Group Growth ETFvs. Q1 2025SEC
Q1 2025Apr 28, 2025477$183.3MMSFTAAPLFirst Tr Exchng Traded FD VIvs. Q4 2024SEC
Q4 2024Feb 6, 2025489$193.7MMSFTAAPLFirst Tr Exchng Traded FD VIvs. Q3 2024SEC
Q3 2024Oct 25, 2024459$194.7MMSFTAAPLFirst Tr Exchng Traded FD VIvs. Q2 2024SEC
Q2 2024Jul 31, 2024462$181.1MMSFTAAPLFirst Tr Exchng Traded FD VIvs. Q1 2024SEC
Q1 2024Apr 26, 2024457$176.2MMSFTAAPLFirst Tr Exchng Traded FD VIvs. Q4 2023SEC
Q4 2023Feb 6, 2024452$113.2MAAPLFirst Tr Exchange-Traded AlpSBUXvs. Q3 2023SEC
Q3 2023Oct 25, 2023453$148.8MMSFTFirst Tr Exchange-Traded FDAAPLvs. Q2 2023SEC
Q2 2023Jul 31, 2023478$159.4MMSFTFirst Tr Exchange-Traded FDAAPLvs. Q1 2023SEC
Q1 2023May 9, 2023484$147.4MMSFTFirst Tr Exchange-Traded FDAAPLvs. Q4 2022SEC
Q4 2022Jan 23, 2023480$129.3MMSFTFirst Tr Exchange-Traded FDAAPLvs. Q3 2022SEC
Q3 2022Nov 7, 2022495$128.6MMSFTAAPLFirst Tr Exchange-Traded FDvs. Q2 2022SEC
Q2 2022Aug 12, 2022501$137.0MMSFTAAPLFirst Tr Exchange-Traded FDvs. Q1 2022SEC
Q1 2022May 11, 2022536$163.1MMSFTAAPLSBUXvs. Q4 2021SEC
Q4 2021Feb 3, 2022563$169.7MMSFTAAPLSBUXvs. Q3 2021SEC
Q3 2021Nov 5, 2021578$163.4MMSFTSBUXAAPLvs. Q2 2021SEC
Q2 2021Aug 9, 2021582$163.9MMSFTSBUXAAPLvs. Q1 2021SEC
Q1 2021May 12, 2021639$161.3MMSFTSBUXAAPL–SEC

13D and 13G filings

Companies where Bellevue Asset Management, LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Bellevue Asset Management, LLC does not currently report owning 5% or more of any company.

Latest filings

10 filings on file made by Bellevue Asset Management, LLC or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Bellevue Asset Management, LLC
CompanyFiled (ET)FilerFormStakeChangeEvent dateFiling
JBIOJade Biosciences, Inc.Aug 14, 202611:57 AM ETBellevue Group AGand 1 other13G/A5.00%3.06M shares−1.80 ppfrom 6.80%Jun 30, 2026SEC
VRDNViridian Therapeutics, Inc.May 15, 20262:38 PM ETBellevue Group AGand 1 other13G6.60%6.73M sharesNewMar 31, 2026SEC
CLDXCelldex Therapeutics, Inc.May 15, 20262:37 PM ETBellevue Group AGand 1 other13G/A1.50%1.20M shares−3.90 ppfrom 5.40%Below 5%Mar 31, 2026SEC
JBIOJade Biosciences, Inc.Feb 17, 20264:01 PM ETBellevue Group AGand 1 other13G6.80%3.34M sharesNewDec 16, 2025SEC
MGNXMacrogenics IncJan 6, 20267:27 PM ETBellevue Group AGand 1 other13G/A0.00%0 shares−15.70 ppfrom 15.70%Below 5%Dec 5, 2025SEC
AGIOAgios Pharmaceuticals, Inc.Dec 5, 20255:42 PM ETBellevue Group AGand 1 other13G/A0.00%0 shares−6.10 ppfrom 6.10%Below 5%Nov 19, 2025SEC
IMCRImmunocore Holdings plcNov 14, 20258:00 PM ETBellevue Group AGand 1 other13G5.60%2.80M sharesNewAug 20, 2025SEC
CLDXCelldex Therapeutics, Inc.Nov 14, 20257:58 PM ETBellevue Group AGand 1 other13G5.40%3.62M sharesNewAug 18, 2025SEC
AGIOAgios Pharmaceuticals, Inc.Jul 7, 20257:32 PM ETBellevue Group AGand 1 other13G6.10%3.52M sharesNewJun 1, 2025SEC
MGNXMacrogenics IncJul 7, 20257:20 PM ETBellevue Group AGand 1 other13G15.70%9.93M sharesNewJun 1, 2025SEC